GeneralConnection.com ➔ Dictionary
Dictionary Search

actinium

Synonyms

Noun

1. Ac

2. atomic number 89, chemical element, element

Usage
High-energy resolution X-ray spectroscopy reveals bonding characteristics of La - Nature
Promising Phase 1 Data for Actinium-225 Presented at 2026 ASCO GU - Targeted Oncology
Radiopharma Sector Races To Secure Actinium-225 Supply as Pipelines Expand - BioSpace
How Eckert & Ziegler’s Actinium-225 Radio-DARPin Partnership (XTRA:EUZ) Has Changed Its Investment Story - simplywall.st
Niowave Signs Long-Term Actinium-225 Supply Agreement With Novartis - NucNet | Independent Nuclear News
Actinium Pharmaceuticals to Unveil the Multi-Tumor Potential of ATNM-400, a First-in-Class Actinium-225 Radiotherapy, with Data in Non-Small Cell Lung Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeut - PR Newswire
Why Is Actinium Pharmaceuticals Stock Rising Today? - Stocktwits
Jeri Kim: Thrilled to Join Actinium Pharmaceuticals as VP, Head of Solid Tumor Clinical Development - Oncodaily
AstraZeneca locks in long-term actinium-225 supply with Niowave - The Pharma Letter
Are Medical Stocks Lagging Actinium Pharmaceuticals (ATNM) This Year? - Yahoo Finance
Novartis prunes its pipeline | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Actinium Pharmaceuticals Presents New Data Demonstrating Potent and Durable Efficacy of ATNM-400, a First-in-Class Multi-Tumor Actinium-225 Radiotherapy, at the 32nd Annual Prostate Cancer Foundation Scientific Retreat - PR Newswire
Laser spectroscopy and CP-violation sensitivity of actinium monofluoride - Nature
Actinium Pharmaceuticals Announces ATNM-400 Data Demonstrating Potent Efficacy in Triple-Negative Breast Cancer and Ability to Overcome Endocrine and HER2-Targeted Therapy Resistance Being Presented at the San Antonio Breast Cancer Symposiu - PR Newswire
Actinium Pharmaceuticals Presents New Preclinical Data Demonstrating Potent Anti-Tumor Activity of ATNM-400 Across Multiple Breast Cancer Subtypes Including Hormone Receptor-Positive, Triple-Negative, and Tamoxifen- and HER2 Therapy-Resistant Br - PR Newswire
Actinium Announces Superior Anti-Tumor Activity of ATNM-400 in Lung Cancer Compared to the Leading First, Second and Third-Line Approved EGFR Mutant Therapies and Mechanistic Synergy with Osimertinib at the AACR-NCI-EORTC International Confer - PR Newswire
Actinium to Present ATNM-400 Preclinical Data Highlighting Durable Tumor Control and Ability to Overcome Resistance to Standard-of-Care Prostate Cancer Therapies at the 32nd Annual Prostate Cancer Foundation Scientific Retreat - PR Newswire
Actinium Pharmaceuticals, Inc. to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference - PR Newswire
Actinium Pharmaceuticals, Inc. to Highlight ATNM-400 Data in Hormone-Resistant and HER2-Resistant Breast Cancer at the 2025 San Antonio Breast Cancer Symposium, Expanding Pan-Tumor Profile Across Three Solid Tumor Indications - PR Newswire
Actinium Presents Data Supporting Paradigm Changing Potential of ATNM-400 in Prostate Cancer Demonstrating Its Superior Efficacy and Improved Survival in Treatment Resistant Tumor Models versus Pluvicto and ARPI Therapy, and Also Enhanced Efficac - PR Newswire
Novartis taps Niowave for supply of radiopharmaceutical isotope - Fierce Pharma
Actinium Pharmaceuticals, Inc. to Present Two Abstracts at the 2026 AACR Annual Meeting - Yahoo Finance
Phase 1 Trial of an Actinium-Labeled KLK2-Targeting Antibody for mCRPC - Michael Morris - UroToday
Belgium’s PanTera Begins Construction Of Dedicated Actinium-225 Facility - NucNet | Independent Nuclear News
Comparing Lead-212 and Actinium-225 Alpha Emitters for Prostate Cancer Treatment "Presentation" - Alfred Morgenstern - UroToday
Actinium Highlights Expanded Data Set for ATNM-400 in Prostate Cancer Demonstrating Superior Efficacy to Enzalutamide and Ability to Overcome Resistance to ARPI Therapy and PSMA-Ac-225/Lu-177 Labelled Radiotherapy at the Society of Nuclear Medic - PR Newswire
BIOEMTECH and NorthStar Medical Radioisotopes Announce Strategic Supply Agreement for Actinium-225 to Support Preclinical Radiopharmaceutical Research - Business Wire
The Race for the Global Radiotherapy Cancer Market; Actinium Pharmaceuticals' (ATNM) Big Bet - TMX Newsfile
Actinium-PSMA J591 After Prior Lutetium Therapy in Metastatic Prostate Cancer - Scott Tagawa - UroToday
Lilly misses its Point | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Is Actinium Pharmaceuticals (ATNM) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Niowave Expands Global Supply Agreement with AstraZeneca to Deliver Actinium-225 for Next-Generation Cancer Therapies - PR Newswire
Novartis Actinium 225 Deal Supports Radioligand Focus And Valuation Case - Yahoo Finance
Actinium Pharmaceuticals stock rises after promising breast cancer therapy data - Investing.com
SK biopharmaceuticals secures European supply of actinium-225 through deal with Germany's Eckert & Ziegler - koreabiomed.com
Stibbe assists PanTera with the development of its Actinium Production Center - Stibbe
Niowave and Novartis Enter Global Actinium-225 Supply Agreement to Advance Next-Generation Cancer Therapies - Yahoo Finance
Ratio Therapeutics and TerraPower Isotopes Sign Supply Agreement for Actinium-225 For Targeted Radiotherapeutics - PR Newswire
New NIST Standard Helps Deliver the Right Dosage of Cancer-Fighting Drugs - National Institute of Standards and Technology (.gov)
ASCO 2025: PSMA-Targeted Actinium-225 Therapy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): Baseline and Follow-up PSMA PET Parameters Associated with Outcomes - UroToday
Preclinical data show promise of ATNM-400 for prostate cancer - Urology Times
Radioactive protein drugs take aim at small cell lung cancer tumors - Stock Titan
Actinium Announces Enrollment of First Patient in the Iomab-ACT Commercial CAR-T Trial at the University of Texas Southwestern Medical Center - PR Newswire
AtomVie Global Radiopharma and TerraPower Isotopes Announce Strategic Supply Agreement for Actinium-225 to Advance Radiopharmaceutical Development and Manufacturing - PR Newswire
Clinical Experience with Actinium-PSMA Across Multiple Treatment Centers "Presentation" - Alfred Morgenstern - UroToday
A Look At Eckert & Ziegler’s (XTRA:EUZ) Valuation As Actinium‑225 Production Scales Up - simplywall.st
SK Biopharm secures Actinium-225 supply in Europe with Eckert & Ziegler deal - The Korea Herald
Actinium Presents Data Showing ATNM-400 is More Efficacious than Pluvicto and is Highly Efficacious after Pluvicto Resistance in Prostate Cancer Tumor Models at the American Association for Cancer Research Annual Meeting - PR Newswire
Actinium Pharmaceuticals Provides Business Update After Presentation at Trump Mar-A-Lago Club Announcing Novel Non-PSMA Prostate Cancer Radiotherapy ATNM-400 and Outlining Revitalized Clinical Pipeline with 2025 Corporate Objectives - PR Newswire
Mayo Clinic treats first person in the US with a novel radiopharmaceutical therapy for breast cancer - Mayo Clinic News Network
First Patient With Breast Cancer Dosed With Novel Radioactive Medicine - Cure Today
Bayer initiates Phase I study targeting GPC3 with actinium-225 radiopharmaceutical in patients with advanced hepatocellular carcinoma - Bayer
Actinium Highlights ATNM 400 Progress at SNMMI Conference - Yahoo Finance
UCLA Health launches novel clinical trial for recurrent prostate cancer - UCLA Health
Actinium Pharmaceuticals to Present Business Update at Trump Mar-A-Lago Club Today - PR Newswire
PanTera breaks ground on Ac-225 facility - Nuclear Engineering International
Niowave And Novartis Enter Global Actinium-225 Supply Agreement To Advance Next-Generation Cancer Therapies - TradingView
Actinium Pharmaceuticals, Inc. Announces Principal Financial Officer Changes, Effective as of February 27, 2026 - marketscreener.com
Actinium Pharmaceuticals Announces Supply Agreement with Eckert & Ziegler for Ac-225 Radioisotope to Support Comprehensive Development Activities - PR Newswire
Actinium Pharmaceuticals Announces ATNM-400 a Novel Non-PSMA Targeting First in Class Prostate Cancer Radiotherapy Leveraging Actinium-225 - PR Newswire
Ratio, Ionetix ink separate deals to speed production of in-demand radiopharmaceutical isotopes - Fierce Pharma
Surge in Radiopharmaceutical R&D Puts Pressure on Unique Supply Chain - BioSpace
Stability as a Strategic Asset in Biotech's Turbulent Climate - AD HOC NEWS
Actinium Pharmaceuticals Advances ATNM-400 B7-H3 Candidate Into Phase 1 Clinical Trial in South Africa - openPR.com
Actinium Pharmaceuticals, Inc. to Present Two Abstracts at the 2026 AACR Annual Meeting - Finansavisen
Botulinum Toxin and Scopolamine for Radiation-Induced Salivary Gland Toxicity in Metastatic Prostate Cancer - The ASCO Post
IONETIX Corporation and AlfaRim Medical B.V. announce a strategic partnership to fast-track commercial production of Actinium-225 - PR Newswire
Medical Radioisotopes and Stable Isotope Surge - Mirage News
Actinium Pharmaceuticals Announces Research Collaboration with Memorial Sloan Kettering to Support Further Clinical Expansion of Actimab-A's Backbone Therapy Strategy - PR Newswire
Promising Data Presented on Novel Radiotherapy for AML, MDS, Myeloid Malignancies - Docwire News
BMS's RayzeBio unit opens $160M radiopharma plant in Indianapolis - FirstWord Pharma
Radiopharmaceutical production gets boost from radium transfers to U.S. - AuntMinnie
IPO Launch: Can Actinium Pharmaceuticals Inc stock double in the next year - 2026 Short Interest & High Yield Equity Trading Tips - baoquankhu1.vn
Actinium Pharmaceuticals Announces Clinical Trial Program in Solid Tumors Combining Actimab-A with PD-1 Checkpoint Inhibitors KEYTRUDA® and OPDIVO® - PR Newswire
Groundbreaking Cancer Therapy Clinical Trial with U.S. Department of Energy’s Accelerator-Produced Actinium-225 Set to Begin this Summer - Newswise
BMS, RayzeBio launch radiopharmaceutical manufacturing site in Indianapolis - Fierce Pharma
Company mines ORNL's nuclear waste for nuclear medicine - Oak Ridger
Bayer Initiates Phase I Study Targeting GPC3 With Actinium-225 Radiopharmaceutical in Patients With Advanced Hepatocellular Carcinoma - Business Wire
Actinium launches ATNM-400 radiotherapy for prostate cancer treatment - AuntMinnie
Bristol gets a new prostate cancer target | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
AstraZeneca (AZN) Expands Actinium-225 Supply Agreement with Nio - GuruFocus
Actinium Pharmaceuticals Announces Publication of Actimab-A + CLAG-M Trial Results in Patients with Relapsed or Refractory Acute Myeloid Leukemia in the Peer-Reviewed Journal Leukemia - PR Newswire
Aug Shorts: What is the dividend yield of Actinium Pharmaceuticals Inc - 2025 Investor Takeaways & Technical Pattern Alert System - baoquankhu1.vn
Market Rankings: Is Actinium Pharmaceuticals Inc undervalued by DCF analysis - July 2025 Levels & AI Forecast Swing Trade Picks - baoquankhu1.vn
Mayo Clinic pioneers new breast cancer treatment - KIMT
Patented technology removes key radioactive contaminant in critical minerals processing - ANSTO
Production and Quality Control of Actinium-225 Radiopharmaceuticals - International Atomic Energy Agency
AtomVie Global Radiopharma and TerraPower Isotopes Announce Strategic Supply Agreement for Actinium-225 to Advance Radiopharmaceutical Development and Manufacturing - PA Media
Actinium Pharmaceuticals: Clinical Milestone and Promising Data Fuel Oncology Pipeline - AD HOC NEWS
Nusano Signs Multi-Isotope Supply Agreement with Cellectar Biosciences to Fuel Cancer Drug Development - TechBuzz News
Actinium chelation and crystallization in a macromolecular scaffold - Nature
Ac and other radionuclidic impurities in mass-separated - Nature
Small biotech joins list of health companies taking a trip to Trump's Mar-a-Lago - Endpoints News
ACCEL Trial Tests Actinium-225-PSMA-62 in Prostate Cancer - Ramy Saleh - UroToday
TerraPower Isotopes Brings Actinium-225 to Market - TerraPower
Actinium Pharmaceuticals, Inc. to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference - Finansavisen
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - StreetInsider
ATNM Stock Price, News & Analysis - Stock Titan
Caught in the Actinium - Berkeley Lab News Center (.gov)
Novartis goes earlier with actinium | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Foreign Language Equivalents
Foreign Language Equivalents of 'actinium'
Language Equivalent   Language Equivalent
French actinium    Spanish
Misspellings - Typos
actimium,   atcinium,   actinim,   actiniium,   acrinium,   actinnium,   actiinium,   catinium,   actinuim,   actiinum,   actiium,   actonium,   actiniim,   actniium,   avtinium,   acttinium,   acctinium,   sctinium,   actiniu,,   actinimu,   actiniuum,   actinuum,   actiniu,   actiniym,   atinium,   actibium,   actinoum,   actnium,   actiniun,   actiniumm,   acyinium,   aactinium,   ctinium,   axtinium,   actinum,   actunium,   acitnium,   acinium
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z